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Abstract
Background: To investigate the associations of genetic polymorphism with high-density lipoprotein-cholesterol (HDL-C) levels in
Iranian adolescents.
Methods: This multicentre study was conducted on 10 - 18 year-old students from 27 provinces in Iran. Logic regression approach
was used to determine the main effects and interactions of polymorphisms related to HDL-C levels.
Results: The rs708272 polymorphism was significantly related to HDL-C levels. Moreover, rs708272 increased HDL-C levels and had a
protective effect on HDL-C. The interaction of rs2230808 and rs5880 polymorphisms as well as the interaction of rs320 and rs708272
polymorphisms were associated with lower HDL-C levels. Furthermore, the interaction of rs320 and rs1801177 polymorphisms was
associated with lower HDL-C levels.
Conclusions: We found that not only single SNPs, but also interactions of several SNPs affect HDL-C levels. Given the high prevalence
of low HDL-C in Middle Eastern populations, further genetic studies are required for detailed analysis.
Keywords: Polymorphism, High-Density Lipoprotein, Pediatrics, Logic Regression
1. Background
Non-communicable diseases and notably cardiovascu-
lar diseases (CVD) are the primary reason for mortality and
the main health burden worldwide (1). Serum lipids and
lipoproteins in the pediatric age group are shown to be
predictive of future symptomatic CVDs (2). Studies show
that lipoproteins, as well as other cardiovascular risk fac-
tors, track from childhood to adulthood (3). The assess-
ment of the early onset of CVD risk factors in childhood
is important to determine optimal preventive measures,
since determining the early development of adult CVDs
may help reduce the mortality rate (4, 5). Among lipids,
high-density lipoprotein cholesterol (HDL-C) is a protec-
tive element against CVD (6). A study presented that hav-
ing HDL-C 6 to 7 mg/dL higher than average leads to 20% to
27% decrease in the risk of CVD (7).
Low HDL-C levels are quite prevalent in the Middle-
Eastern countries (8). Population-based studies in Iran pre-
sented a prevalent low HDL-C among children and ado-
lescents (4, 9, 10). Furthermore, its fifth percentile of Ira-
nian pediatric population is lower than that of European
and American population (11, 12). Moreover, it is well docu-
mented that HDL-C is affected by both genetic contexts and
environmental factors, such as demographics, diet, smok-
ing, and weight disorders (13, 14). Although hormonal, en-
vironmental, and social factors could specify HDL-C levels,
the genetic component accounts up to 76% of the variation
in HDL-C levels (15). Single nucleotide polymorphism (SNP)
is the most prevalent genetic discrepancy (16). In the eval-
uation of genotype data, the effect size of associations be-
tween one SNPs and a response is usually small. Therefore,
it is assumed that not only single SNPs but also interactions
of several SNPs is particularly important (17). Most genetic
studies on lipid profiles focused on individual SNPs while
SNP-SNP interactions are suggested to have a great effect
on the structure of complex diseases. As an example, Kel-
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ishadi et al. investigated the genetic association with low
concentrations of HDL-C in a pediatric population, (18). In
this study, single SNPs were taken into accounts and the
polymorphism of ApoE gene was not included.
To the best of our knowledge, no analysis has been
performed to evaluate an association between the interac-
tion of SNPs and low HDL-C in Middle Eastern adolescents.
Therefore, the aim of the present investigation was to de-
termine the influence of some polymorphisms (and their
interactions) on HDL-C levels performed for the first time
on children and adolescents.
2. Methods
2.1. Study Populations
The subjects in this study were randomly determined
between individuals in the CASPIAN-III study, Childhood
and Adolescence Surveillance and Prevention of Adult Non-
communicable disease study. This survey was performed
to determine risky behaviors in Iranian school students
(2009 - 2010).
The original study included 5528 10 - 18 year-old stu-
dents selected from Iranian urban and rural regions (19).
A total of 734 frozen blood samples were selected.
Low HDL-C levels were determined as concentrations
of < 40 mg/dL. Elevated lipid was considered as total
cholesterol higher or equal to 200 mg/dL, low-density
lipoprotein cholesterol (LDL-C) higher or equal to 130
mg/dL, and triglycerides higher or equal to 150 mg/dL.
High waist circumference was determined as WC higher
or equal to 90th percentile of the population studied. El-
evated fasting blood sugar was defined as FBS higher or
equal to 100 mg/dL. Blood pressure higher or equal to
130/85 mmHg was considered as elevated BP (20).
Normal weight Underweight, overweight, and obe-
sity were determined as a BMI Z-score according to world
health organization (WHO) definition (21).
Polymorphisms of LPL rs1801177, LPL rs320, LPL rs328,
ABCAI rs2066718, ABCAI rs2230808, CETP rs708272, CETP
rs5880, APOC3 rs5128, APOA1 rs2893157, APOA5 rs662799,
and ApoE genes related to HDL-C disorder were analyzed
(22). Each SNP was represented by the values 0, 1, and 2
based on the pairs of nucleotide. We recoded this variable
into 2 binary variables corresponding to a dominant gene
(if SNP has at least one variant allele) and a recessive gene
(if SNP has 2 variant alleles). Using this method, we gener-
ated 2p binary predictors out of p SNPs (23).
2.2. Genetic Studies
2.2.1. DNA Extraction
DNA was extracted from peripheral blood by using the
QIAamp DNA Blood Mini kit (Qiagen, Germany). Corbett
rotor-gene 6000 instruments (Corbett Research Pty Ltd,
Sydney Australia) were used for Real-time PCR and high-
resolution melt analysis. Primers were produced by Bea-
con Designer 7.91 to flank the genomic regions (PREMIER
Biosoft International, USA, and TIB MOLBIOL (Germany)
were used for synthesizing.
The Standard conditions of amplicons production us-
ing type-it HRMkit (Qiagen, Germany) were used (24). The
sequence-proven major and minor allele homozygote and
heterozygote controls were then included. The HRM anal-
ysis was performed, and the samples were clustered (24).
2.3. Statistical Analysis
The continuous variables were shown as mean and
standard deviation. However, on the other hand, frequen-
cies and percentages were used for categorical variables.
The t-test andχ2 were used to compare the continuous and
categorical variables in boys and girls, when appropriate.
The association between polymorphisms and other covari-
ates interactions and HDL-C levels was analyzed using logic
regression.
Few approaches were proposed for the direct detec-
tion of statistical interactions between SNPs in order to en-
hance the statistical power of the studies. Logic regression
was recently proposed as a generalized regression method
to identify interactions between binary predictors associ-
ated with a response variable. It can detect complicated
interactions between predictors that could play important
roles in genetics or discover prognostic factors in medical
data. This technique was efficiently applied on SNP data
(23).
The form of the logic regression model is as below:
(1)h [E (Y |X)] = β0 +
∑n
i=1
βiLi +
∑m
j=i
βj+nZj
where h(.) is an appropriate link function for the re-
sponse and the predictors, e.g. linear (h (E [Y|X]) = E [Y]),
and logistic regression (h (E [Y|X]) = log(E [Y]/(1 - E [Y]))). X
is the covariate matrix, with βi as parameters and the Li as
Boolean combinations of the binary predictors such as x2
and x5
c or x7, with the operator ‘c’ as complement. Further-
more, the Zj are extra confounders. For each model, a score
function was defined reflecting the “quality” of the model
under consideration. We endeavored to find Boolean com-
binations minimizing the scoring function related to the
model. Simulated annealing search algorithm was used to
search for the best Boolean combinations and estimation
of βj (23).
The association between combination of predictors
and low HDL-C level was assessed by the randomization
test. The best model was first fitted to the data, the re-
sponse was permuted in random, and the best model was
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re-fitted. This procedure was repeated several times. If
the entire scores of the permuted data were considerably
worse than that of the original data, the information ex-
isted in the predictors; otherwise, there was no connection
between the predictors and the response (23).
To avoid over-fitting in logic regression models, the
cross-validation test was applied to determine the optimal
model size. The data were split into k equal parts. Then, k
times, one partition was left as a test set, and for each pos-
sible model size, the best model was selected using k -1 out
of k parts, after which the score function on the remaining
test set part was computed. For each level of model size,
the k score function was added and the model size with the
smallest overall score function was selected (23).
Logic regression with logit link function was used to
recognize the relationship between the input predators
and the outcome. We applied R software (version 3.3.0) for
analyzing the data.
3. Results
The average age of the adolescents was 14.66 (2.6) years
with the male predominance of 51.6% (sex ratio = 1.068). Ta-
ble 1 represents the summary of demographic and clinical
characteristics of the study subjects by gender.
Genotype and SNP allele frequencies were used to as-
sess genetic association with HDL-C levels (Table 2). None
of the SNP distributions represented the deviation from
Hardy-Weinberg equilibrium.
Figure 1 shows the results from the null model random-
ization test. The score of the NULL, the best scoring, and
that of the randomization models were compared. Accord-
ingly, we can conclude that there is an association between
the predictors and the low HDL-C.
Figure 1. The Binomial Deviance Score of Randomization Test
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The scores were obtained from the NULL-model randomization procedure.
Figure 2 displays the result of the cross-validation test.
Accordingly, the model with 4 trees and 7 leaves was opti-
mal in terms of the test set deviance and the model size.
Figure 2. The Test Scores Obtained by Cross-Validation with Various Numbers of
Leaves and Trees in the Logic Regression Models
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The numbers in the squares present the number of trees and the number of leaves
was indicated by the model size.
Figure 3 displays the ROC curve of fitted model. The
Area under the ROC curve was 0.87 (95% CI 0.81, 0.90) in-
dicating the high performance of the proposed method.
Figure 3. Receiver Operating Characteristics (ROC) Curve for the Fitted Logic Model
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The area under the curve is 0.87 (P < 0.05) showing the Boolean Combinations of
polymorphisms identified by the logic regression model, has a predictive value for
HDL-C levels.
Table 3 presents the optimal combination rules for low
HDL-C based on the logic regression. The model contains 4
logic combinations significantly affecting the low level of
the HDL-C:
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Table 1. Characteristics of the Participants
Variable Total (N = 734) Boys (N = 379) Girls (N = 355) P Value
Age, ya 14.66± 2.61 14.56± 2.62 14.76± 2.59 0.30
BMI, kg/m2 a 19.14± 4.08 19.43± 4.20 18.82± 3.93 0.04c
HDL-C, mg/dLa 49.50± 21.93 48.88± 21.23 50.16± 22.67 0.43
High FBSb 90 (12.26) 35 (9.23) 55 (15.49) 0.01c
High WCb 100 (13.62) 49 (12.93) 51 (14.37) 0.57
High TCb 43 (5.86) 21 (5.54) 22 (6.2) 0.71
High LDLb 58 (7.90) 30 (7.92) 28 (7.89) 0.99
High TGb 64 (8.72) 28 (7.39) 36 (10.14) 0.19
Elevated BPb 23 (3.13) 10 (2.64) 13 (3.66) 0.43
Abbreviations: BMI, Body Mass Index; BP, Blood Pressure; FBS, Fasting Blood Sugar; HDL-C, High Density Lipoprotein Cholesterol; LDL, Low Density Lipoprotein Choles-
terol; TC, Total Cholesterol; TG, Triglycerides; WC, Waist Circumference.
aValues are expressed as mean± SD.
bValues are expressed as n (%).
cSignificant values.
The first combination (L1) contains “((rs2230808 = GG)
or (rs5880 6= CC))”. This combination indicates that sub-
jects with the GG genotype of ABCA1 rs2230808 or not CC
genotype of CETP rs5880 have an odds ratio of 3.65 (95% CI
2.23, 5.98) with low levels of the HDL-C, comparing to the
other cases.
The second combination (L2) is explained by the inter-
action of LPL rs320 and LPL rs1801177 polymorphisms. The
estimated odds ratio for this combination was 2.12 (95% CI
1.4, 3.2), inferring that G allele of LPL rs1801177 and GG geno-
type of LPL rs320 gene is associated with low HDL-C levels.
The third combination (L3) contains “((rs320 6= TT) or
(rs708272 6= TT))”. This form suggests that not TT genotype
of LPL rs320 or not TT genotype of CETP rs708272 is asso-
ciated with higher odds of low HDL-C levels. The odds ra-
tio associated with L3 was 1.55 (95% CI 1.10, 2.17), indicating
that, as a group, the subjects who complies with L3, are es-
timated to have higher odds of low HDL-C levels compared
to the other subjects.
The fourth combination (L4) was entirely solely by CETP
rs708272 polymorphism. The odds ratio related to this
combination was 0.071 (9% CI 0.05, 0.1), inferring that T al-
lele of rs708272 polymorphism is related with high HDL-
C levels. The deviance as the model score function was
562.64.
4. Discussion
In this cross-sectional multi-center study, we investi-
gated the effect of 11 genetic variants on the low HDL-C lev-
els phenotypes and identified SNPs that were simultane-
ously associated with the HDL-C levels of adolescents. Al-
though many studies examined the relationship of single
SNP and low HDL-C levels, separately, only few studies ana-
lyzed interactions of SNPs that associated with low HDL-C
levels.
In the analysis of genotype data, the effect size of as-
sociations between single SNPs and a response of interest
are usually small. Thus it is assumed that not only single
SNPs but also interactions of several SNP are effective. The
logic regression is a novel approach for discovering inter-
actions, specifically Boolean combinations of factors that
are associated with the response variable (25). There are
several methods proposed in the literature to improve the
logic regression such as logic feature selection, (26). It is
possible to select important interactions first and to de-
sign the final model based upon such predictors. Logic fea-
ture selection did not improve the quality of the proposed
regression model. However, this method was used as an
extension to our regression for low HDL-C level prediction
(classification), whose results are shown in the supplemen-
tary file, Appendix 1.
Previous studies showed that ApoE gene polymor-
phisms were associated with CVD and affected the lipid
profile. The e4 allele was shown as an independent risk fac-
tor for Type 2 diabetes mellitus and cardiovascular disease
(27). However, in our study, the relationship between the
ApoE careers and HDL-C levels in adolescents was not sig-
nificant. In our study, ApoE carriers were significantly de-
pendent with rs708272 (P value <0.01), rs2230808 (P value
< 0.05), and rs320 (P value < 0.001) polymorphisms. Such
variables were significant in our model. Thus, discarding
the ApoE variable would decrease the model redundancy.
Meanwhile, an association with ApoE and HDL-C, levels has
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Table 2. SNP Genotype and Allele Frequencies in the Study Populationa
Polymorphism Genotype and Allele
LPL rs1801177 genotypes AA AG GG
691 (94.1) 43 (5.9) 0
LPL rs320 genotypes GG GT TT
259 (35.3) 336 (45.8) 139 (18.9)
LPL rs328 genotypes CC CG GG
580 (79) 139 (18.9) 15 (2)
ABCAI rs2066718 genotypes GG GA AA
704 (95.9) 30 (4.1) 0
ABCAI rs2230808 genotypes AA AG GG
432 (58.9) 248 (33.8) 54 (7.4)
CETP rs708272 genotypes CC CT TT
268 (36.5) 371 (50.5) 95 (12.9)
CETP rs5880 genotypes CC CG GG
638 (86.9) 92 (12.5) 4 (0.5)
APOC3 rs5128 genotypes CC CG GG
612 (83.4) 118 (16.1) 4 (0.5)
APOA1 rs2893157 genotypes GG GA AA
529 (71.7) 193 (26.3) 15 (2)
APOA5 rs662799 genotypes CC CT TT
722 (98.4) 5 (0.7) 7 (1)
ApoE alleles e2 e3 e4
31 (4.2) 654 (89.1) 49 (6.7)
aABCA1, gene encoding ATP binding cassette transporter A1; APOA1, gene encod-
ing apolipoprotein (apo) A-I; APOA5, gene encoding apo A-V; APOC3 gene encod-
ing apo C-III; CETP, gene encoding cholesteryl ester transfer protein; LPL, gene
encoding lipoprotein lipase.
been observed in some but not in all studies in the litera-
ture (28, 29).
Our findings showed that individuals without CC geno-
type of CETP rs708272 polymorphism have upper HDL-C
levels. In the other words, T allele of rs708272 polymor-
phism is associated with raised levels of HDL-C. A meta-
analysis published in 2003 has systematically shown that
CETP rs708272 polymorphism is associated with HDL-C lev-
els (30). The lack of the T allele of rs708272 polymorphism
of the CETP gene was related to CAD in the Chinese pop-
ulation only and T allele of the rs708272 was significantly
related to higher HDL-C levels in Chinese male (31). The T
allele of rs708272 polymorphism was related to elevated
plasma HDL-C levels in the Chinese obese population (32).
A national study showed that rs708272 polymorphism was
protective on dyslipidemia in Iranian children (33). It was
shown that the C allele of rs708272 is related to increased
CVD and type 2 diabetes mellitus risks (34). In the other
study, the relationship between T allele and higher HDL-
C levels in Greek children were observed (35). A meta-
analysis of 13,677 individuals indicated that the rs708272
polymorphism was highly related to HDL-C concentration
and the risk of atherosclerotic CVD, ultimately (36). Fur-
thermore, a significant relation of the T allele of rs708272
polymorphism with high HDL-C levels has been reported
for the Framingham (37), Chinese (38), Iranian (39), and
Tunisian populations (40).
We observed that an interaction of rs2230808 polymor-
phism in ABCA1 gene and rs5880 polymorphism in CETP
gene is associated with HDL-C levels. Individuals with GG
genotype of rs2230808 polymorphism or G allele of rs5880
have lower HDL-C levels comparing to other subjects in-
dicating that both the main effects of this polymorphism
and their interactions can affect the HDL-C concentration.
The replacement of C by G at amino acid 373 of CETP re-
sulted in the rs5880 polymorphism. The adverse effect of
carriers of the rs5880 polymorphism on the HDL-C levels
may be explained by increasing plasma CETP concentra-
tion (41). The rs5880, CG, and GG genotypes were affili-
ated with 17.2%, 95.8% lower large HDL-C particle concen-
trations, and related with 7% and 41% lower HDL-C levels,
respectively (42). The G allele of rs5880 was shown to re-
late to lower HDL-C, while the ischemic CVD risk was un-
expectedly related to being decreased 36% in women with
the G allele after HDL adjusting (43). A previous study pre-
sented that rs5880 polymorphism was negatively associ-
ated with lipid profile and resulted in a 4-fold increase
in the childhood dyslipidemia risk (33). The multi-ethnic
study of Atherosclerosis (MESA) demonstrated that the G
allele of rs5880, which is related to higher CETP concen-
tration (19.5%) and activity (9.4%) and lower HDL-C (6.0%),
is also related to atherogenic effects (44). Studies of the
ABCA1 gene indicated that its both common and rare vari-
ants affect levels of HDL-C and the risk of ischemic CVD (45).
It was shown that rs2066718 and rs2230808 were related to
HDL-C levels (46, 47). Another study in China showed that
G allele of rs2230808 was related to decreased HDL-C level
(48). The Russian population found that rs2230808 poly-
morphism did not affect lipids levels in patients with CVD
(49). Additionally, in the population of China, no relation-
ship between rs2230808 with lipids levels in patients with
type 2 diabetes mellitus was found (50).
Our result showed that an interaction of rs320 poly-
morphism in LPL gene and rs708272 polymorphism in
CETP gene was associated with HDL-C levels. Individuals
with TT genotype of rs320 and TT genotype of rs708272 had
higher HDL-C levels. The relationship between the rs320,
rs1801177, and rs328 polymorphisms with both TG and HDL-
C, as well as myocardial infarction was analyzed in AVCD
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Table 3. The Results of the Fitted Logic Regression Model with 4 Boolean Combinations of 7 Binary Predictor Variables to Study Interaction Effects of SNPs and Other Risk
Factors on HDL-C
Boolean Combination Coefficient Standard Error Odds Ratio 95% Confidence Interval P Value
L1 : ((rs2230808 = GG) or (rs5880 6= CC)) 1.295 0.251 3.65 (2.23, 5.98) < 0.0001
L2 : ((rs320 = GG) and (rs1801177 6= AA)) 0.749 0.211 2.12 (1.4, 3.2) < 0.0001
L3 : ((rs320 6= TT) or (rs708272 6= TT)) 0.436 0.17 1.55 (1.104, 2.165) 0.011
L4 : (rs708272 6= CC) -2.64 0.18 0.071 (0.05,0.1) < 0.0001
AIC 572.64
AUC 0.87
Abbreviations: AIC, Akaike Information Criterion; AUC, Area Under the Curve.
and control subjects. Moreover, it was observed that carri-
ers of the less common allele of the rs320 polymorphism
had 0.04 mmol/L higher HDL-C levels and 0.09 mmol/L
lower triglycerides levels than non-carriers (51). The rs320
GG genotype and rs320 G allele were observed to be signif-
icantly associated with stroke in Indian population. Also,
rs320 GG genotype associated significantly with high lev-
els of TG and low levels of HDL. However, this polymor-
phism did not show any association with LDL-C and VLDL
levels (52). It was reported that in Iranian children and
adolescents, carriers of T allele of rs320 polymorphism are
associated with lower TG and LDL-C and higher TC and
HDL-C (24). Other studies showed that in healthy-weight
men with coronary heart disease, the rs320 polymorphism
alone might impress the HDL-C concentration, in contrast
to rs328 alone, which has no influence on any lipid param-
eters (53).
Our result showed that an interaction of rs320 poly-
morphism and rs1801177 polymorphism in in LPL gene was
associated with HDL-C levels. Individuals without GG geno-
type of rs320 or AA genotype of rs1801177 had higher HDL-
C levels. The G allele of rs1801177 polymorphism is shown
to be associated with lower HDL-C levels and higher LDL-
C levels in Iranian adolescents (24). It was reported that
rs1801177 polymorphism affects serum lipids, and thus in-
crease the CVD risk (54). However, another case–control
study showed that the rs1801177 genotype was not signifi-
cantly correlated with CVD (55).
4.1. Study Limitations and Strengths
Our study was a cross sectional. This is in fact one of
the limitations of our work. However, the pediatric age
group and the region under the study are 2 advantages of
our work in comparison with the state-of-the art.
4.2. Conclusion:
We showed that rs708272 polymorphism in CETP gene
has an important effect on the level of HDL-C, indepen-
dently. Moreover, rs708272 increased HDL-C levels and
had a protective effect on HDL-C. The interaction of ABCA1
(rs2230808) as well as CETP (rs5880) and the interaction of
LPL (rs320) as well as CETP (rs708272) were associated with
lower HDL-C levels. Furthermore, the interaction of LPL
(rs320) and LPL (rs1801177) was associated with lower HDL-C
levels.
Supplementary Material
Supplementary material(s) is available here.
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